HomeMDG1 • SWX
MediGene
CHF 8.76
Dec 4, 10:05:00 PM GMT+1 · CHF · SWX · Disclaimer
StockCH listed securityDE headquartered
Previous close
CHF 8.76
Year range
CHF 8.76 - CHF 17.51
Market cap
16.95M EUR
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(EUR)Jun 2024Y/Y change
Revenue
1.46M-6.00%
Operating expense
5.22M-0.04%
Net income
-4.08M-0.57%
Net profit margin
-280.10-6.99%
Earnings per share
EBITDA
-3.75M0.95%
Effective tax rate
Total assets
Total liabilities
(EUR)Jun 2024Y/Y change
Cash and short-term investments
14.02M-42.88%
Total assets
28.81M-31.69%
Total liabilities
9.15M-23.69%
Total equity
19.66M
Shares outstanding
14.74M
Price to book
6.58
Return on assets
Return on capital
-44.32%
Net change in cash
(EUR)Jun 2024Y/Y change
Net income
-4.08M-0.57%
Cash from operations
-3.54M11.77%
Cash from investing
3.85M201.29%
Cash from financing
2.36M2,998.77%
Net change in cash
2.68M194.29%
Free cash flow
About
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia
Founded
1994
Employees
87
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu